Methods: Data Sources Bias 9
Describe any efforts to address potential sources of bias.
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Study size 10 Explain how the study size was arrived at. Results
Quantitative variables 11
Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why. 
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Results
Other analyses 17
Report other analyses done (e.g. analyses of subgroups and interactions, and sensitivity analyses).
Results
Key results 18
Summarize key results with reference to study objectives.
Discussion
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias.
(19.1) Discuss the implications of using data that were not created or collected to answer the specific research question(s). Include discussion of misclassification bias, unmeasured confounding, missing data, and changing eligibility over time, as they pertain to the study being reported.
Interpretation 20
Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence.
Generalizability 21
Discuss the generalizability (external validity) of the study results.
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Other information
Funding 22
Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based.
Accessibility of protocol, raw data, and programming code N/A (22.1) Authors should provide information on how to access any supplemental information such as the study protocol, raw data, or programming code. ICD 9: 430, 431, 432, 5307, 5310, 5312, 5314, 5316, 5320, 5322, 5324, 5326, 5330, 5332, 5334, 5336, 5340, 5342, 5344, 5346, 5780, 5781, 5693, 5789 R936 , R783, R784, R785,  E626, R814, R786, R937,  R860, R861, R855, R856,  R933, R934, R791, E672 Abbreviations: ACR albumin to creatinine ratio, AF atrial fibrillation, mg milligram, g gram, CI confidence interval *sub-distribution hazard ratio accounting for the competing risk of death Table 5 : Crude number of events for stroke by atrial fibrillation status, eGFR and ACR level with eGFR > 90 ml/min/1.73m 2 /ACR <3 mg/g and absence of atrial fibrillation as referent. 
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